2m 2m 2m 2m 2m 2m 2m
JANUX THERAPEUTS (JANX)
NASDAQ
$16.01-$0.13 (-0.83%)
Price as of Jul 14, 2026 4:08 AM EDT- $984.3MMarket Cap
- -38.35%1-Year Change
- BiotechnologyIndustry
JANUX THERAPEUTS (JANX)
$16.01-$0.13 (-0.83%)
JANX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $16.14 | ||
Change | -$0.26 (-1.59%) | ||
Open | $16.24 | ||
High | $16.36 | ||
Low | $15.87 | ||
Previous Close | $16.40 | ||
Volume | 801,070 | ||
30-Day Average Volume | 1,532,299 | ||
1-Week Change | 4.74% | ||
1-Month Change | 19.03% | ||
1-Year Change | -38.35% | ||
3-Year Change | 28.30% | ||
5-Year Change | -40.99% | ||
Fundamentals | |||
Shares Outstanding | 61.0M | ||
Total Assets | $1.0B | ||
Market Cap | $984.3M | ||
Enterprise Value | $932.5M | ||
Period: QTR TTM FY | |||
Revenue | $3.7M | ||
Net Income | -$24.4M | ||
Free Cash Flow | -$12.6M | ||
EBIT | -$24.4M | ||
EBITDA | -$23.9M | ||
Net Working Capital | $943.1M | ||
EPS | -$0.39 | ||
Enterprise Value/EBITDA | -39 | ||
Enterprise Value/Revenue | 250 | ||
P/B | 1 | ||
P/E | -41 | ||
PEG | -2 | ||
Price/Free Cash Flow | -78 | ||
Price/Operating Cash Flow | -80 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue